NUC01, Placebo to NUC01
NUC-5/PSC
Phase 3 small_molecule active
Quick answer
NUC01, Placebo to NUC01 for primary sclerosing cholangitis (PSC) is a Phase 3 program (small_molecule) at Dr. Falk Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dr. Falk Pharma GmbH
- Indication
- primary sclerosing cholangitis (PSC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active